DK2379066T3 - Anvendelse af opioidantagonister til fremstilling af et lægemiddel til behandling af retinadegenerationssygdomme - Google Patents

Anvendelse af opioidantagonister til fremstilling af et lægemiddel til behandling af retinadegenerationssygdomme

Info

Publication number
DK2379066T3
DK2379066T3 DK08807092.5T DK08807092T DK2379066T3 DK 2379066 T3 DK2379066 T3 DK 2379066T3 DK 08807092 T DK08807092 T DK 08807092T DK 2379066 T3 DK2379066 T3 DK 2379066T3
Authority
DK
Denmark
Prior art keywords
degenery
diseases
retained
medicine
preparation
Prior art date
Application number
DK08807092.5T
Other languages
English (en)
Inventor
Ibrahim Mustafa Iskender Pisak
Mehmet Levent Selamoglu
Nevhiz Pak
Semra Bingol
Original Assignee
Imunek Farma Ilaç Sanayi Ve Ticaret A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imunek Farma Ilaç Sanayi Ve Ticaret A S filed Critical Imunek Farma Ilaç Sanayi Ve Ticaret A S
Application granted granted Critical
Publication of DK2379066T3 publication Critical patent/DK2379066T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
DK08807092.5T 2008-09-16 2008-09-16 Anvendelse af opioidantagonister til fremstilling af et lægemiddel til behandling af retinadegenerationssygdomme DK2379066T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2008/002412 WO2010032073A1 (en) 2008-09-16 2008-09-16 Use of opioid antagonists for the preparation of a medicament in the treatment of retinal degenerative diseases

Publications (1)

Publication Number Publication Date
DK2379066T3 true DK2379066T3 (da) 2014-06-30

Family

ID=41138810

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08807092.5T DK2379066T3 (da) 2008-09-16 2008-09-16 Anvendelse af opioidantagonister til fremstilling af et lægemiddel til behandling af retinadegenerationssygdomme

Country Status (10)

Country Link
US (1) US20110165232A1 (da)
EP (1) EP2379066B1 (da)
CY (1) CY1115269T1 (da)
DK (1) DK2379066T3 (da)
ES (1) ES2475199T3 (da)
HR (1) HRP20140596T1 (da)
PL (1) PL2379066T3 (da)
PT (1) PT2379066E (da)
SI (1) SI2379066T1 (da)
WO (1) WO2010032073A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011040894A1 (en) 2009-10-01 2011-04-07 Mustafa Nevzat Ilaç Sanayii A.Ş. Topical compositions of opioid antagonists and methods for treating skin conditions therewith
TR201002473A2 (tr) 2010-03-31 2011-09-21 Mustafa Nevzat �La� Sanay�� A.�. Herpes zoster hastalığının bır opiat reseptör antagonist kullanılarak tedavi yöntemi.
JP5671609B2 (ja) 2010-05-10 2015-02-18 ユーロ−セルティーク エス．エイ． ヒドロモルホンおよびナロキソンを含む医薬組成物
WO2011141489A1 (en) 2010-05-10 2011-11-17 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
BR112012028656A2 (pt) 2010-05-10 2016-08-09 Euro Celtique Sa combinação de grânulos carregados ativos com ativos adicionais
US20140213605A1 (en) * 2013-01-27 2014-07-31 Remedeye Inc. Methods for treating eye disorders using opioid receptor antagonists
KR102194174B1 (ko) 2013-11-13 2020-12-23 유로-셀티큐 에스.에이. 통증 및 오피오이드 장 기능장애 증후군의 치료를 위한 히드로모르폰 및 날록손

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416886A (en) * 1981-07-29 1983-11-22 Dermall Limited Method of treating pruritis and composition therefor
US4888346A (en) * 1986-10-07 1989-12-19 Bernard Bihari Method for the treatment of persons infected with HTLV-III (AIDS) virus
US5356900A (en) * 1986-10-07 1994-10-18 Bernard Bihari Method of treating chronic herpes virus infections using an opiate receptor antagonist
US4857533A (en) * 1988-12-15 1989-08-15 Baker Cummins Pharmaceuticals, Inc. Method of treatment for autoimmune diseases
DE4222534A1 (de) * 1992-07-09 1994-01-13 Behringwerke Ag Verwendung von Komplement-Inhibitoren zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie von entzündlichen Darm- und Hauterkrankungen sowie Purpura
US6074642A (en) 1994-05-02 2000-06-13 Alexion Pharmaceuticals, Inc. Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis
US6384044B1 (en) * 1999-11-29 2002-05-07 Bernard Bihari Method of treating cancer of the prostate
US20030077301A1 (en) * 1999-12-16 2003-04-24 Maibach Howard I. Topical pharmaceutical composition for the treatment of inflammatory dermatoses
US20030072724A1 (en) * 1999-12-16 2003-04-17 Maibach Howard I. Topical pharmaceutical composition to treat hyperpigmentation of the skin
US6538028B1 (en) * 2000-02-01 2003-03-25 Vanderbilt University Method for inhibiting complement activation
US20030191147A1 (en) * 2002-04-09 2003-10-09 Barry Sherman Opioid antagonist compositions and dosage forms
US20030235542A1 (en) * 2002-06-21 2003-12-25 Maibach Howard I. Topical administration of pharmacologically active bases for skin lightening
US6821523B2 (en) * 2002-06-21 2004-11-23 Dermatrends, Inc. Topical administration of pharmacologically active bases in the treatment of warts
CA2522471A1 (en) * 2003-04-14 2004-10-28 Pain Therapeutics, Inc. Methods for the treatment of pain comprising opioid antagonists
MXPA05011557A (es) * 2003-04-29 2006-03-09 Orexigen Therapeutics Inc Composiciones para afectar perdida de peso.
US20060069086A1 (en) * 2004-09-23 2006-03-30 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
JP2006131545A (ja) * 2004-11-05 2006-05-25 Japan Science & Technology Agency 神経因性疼痛治療剤
ES2714198T3 (es) * 2005-03-07 2019-05-27 Univ Chicago Uso de antagonistas opioideos para atenuar la proliferación y la migración de células endoteliales
US8916195B2 (en) * 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
US8828953B2 (en) * 2009-04-20 2014-09-09 NaZura BioHealth, Inc. Chemosensory receptor ligand-based therapies
US8829020B2 (en) * 2009-07-16 2014-09-09 Mallinckrodt Llc Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
WO2011040894A1 (en) * 2009-10-01 2011-04-07 Mustafa Nevzat Ilaç Sanayii A.Ş. Topical compositions of opioid antagonists and methods for treating skin conditions therewith
TR201002473A2 (tr) * 2010-03-31 2011-09-21 Mustafa Nevzat �La� Sanay�� A.�. Herpes zoster hastalığının bır opiat reseptör antagonist kullanılarak tedavi yöntemi.

Also Published As

Publication number Publication date
CY1115269T1 (el) 2017-01-04
US20110165232A1 (en) 2011-07-07
PT2379066E (pt) 2014-07-04
WO2010032073A1 (en) 2010-03-25
SI2379066T1 (sl) 2014-08-29
ES2475199T3 (es) 2014-07-10
PL2379066T3 (pl) 2014-09-30
HRP20140596T1 (hr) 2014-08-01
EP2379066B1 (en) 2014-03-26
EP2379066A1 (en) 2011-10-26

Similar Documents

Publication Publication Date Title
CY2016053I1 (el) Μεθοδοι αγωγης χρησιμοποιωντας φαρμακευτικες ουσιες συλληψης αμμωνιας
DK2073860T3 (da) Lægemiddelfrigivende coatinger til medicinske indretninger
BRPI0906467A2 (pt) forma de dose farmacêutica
DK2173407T3 (da) Anordning til indgivelse af lægemiddel
DK3456707T3 (da) 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme
BRPI0920514A2 (pt) infusão de fármacos
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
DE602007000323D1 (de) Abgabe von therapeutischen Vorrichtungen
DK2343071T3 (da) Farmaceutiske doseringsformer
DK2274032T3 (da) Anordning til medicinindgivelse
BRPI0920082A2 (pt) forma de dosagem oral de acetaminofeno/tramadol com liberação estendida.
DK2222272T3 (da) Behandling af luftvejssygdom
DK2187878T3 (da) Anvendelse af en betablokker til fremstilling af et medikament til behandling af hæmangiomer
DK2381988T3 (da) Medikamentadministrationsanordning
DK2285808T3 (da) Spiroindolderivater til behandling af parasitsygdomme
DK2451482T3 (da) Kombinationsterapi til behandlingen af diabetes
DK2506712T3 (da) Morfinanderivater til behandling af lægemiddeloverdosering
DK3005986T3 (da) Infusion af lægemidler
DK2627345T3 (da) Formuleringer til behandling af sygdomme i de øvre luftveje
DK1940409T3 (da) Nye lægemiddelkombinationer til behandling af åndedrætssygdomme
DK2236149T3 (da) Medicinsk sammensætning til behandling af respiratoriske infektions-sygdomme
DK2379066T3 (da) Anvendelse af opioidantagonister til fremstilling af et lægemiddel til behandling af retinadegenerationssygdomme
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
DK2271618T3 (da) Farmaceutiske forbindelser
EE201300004A (et) Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks